Chemical Compound Review:
SureCN56848 1-[[5-(4-nitrophenyl)-2...
Synonyms:
KBioGR_000025, KBioGR_000645, KBioSS_000025, KBioSS_002017, CBiol_001748, ...
- Treatment of heat stroke with dantrolene. Lydiatt, J.S., Hill, G.E. JAMA (1981)
- Dantrolene, pelvic neoplasm, and muscle spasms: report of a case. Myers, A. JAMA (1977)
- Letter: Treatment of spasticity in multiple sclerosis with dantrolene. Horne, M.L. JAMA (1976)
- Letter: Dantrolene in amyotrophic lateral sclerosis. Rivera, V.M., Breitbach, W.B., Swanke, L. JAMA (1975)
- Treatment of neuroleptic malignant syndrome with dantrolene. Goekoop, J.G., Carbaat, P.A. Lancet (1982)
- Dantrolene in lethal catatonia. Pennati, A., Sacchetti, E., Calzeroni, A. The American journal of psychiatry. (1991)
- Neuroleptic malignant syndrome. Review of response to therapy. Rosenberg, M.R., Green, M. Arch. Intern. Med. (1989)
- Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report. Nolen, W.A., Zwaan, W.A. Acta psychiatrica Scandinavica. (1990)
- Letter: Hallucinations associated with dantrolene sodium therapy. Andrews, L.G., Muzumdar, A.S., Pinkerton, A.C. Canadian Medical Association journal. (1975)
- Calcium release from skeletal muscle sarcoplasmic reticulum: site of action of dantrolene sodium. Van Winkle, W.B. Science (1976)
- Letter: Dantrolene deposited in connective tissue. Wilkie, O.L. JAMA (1976)
- Ca2+ homeostasis in Brody's disease. A study in skeletal muscle and cultured muscle cells and the effects of dantrolene an verapamil. Benders, A.A., Veerkamp, J.H., Oosterhof, A., Jongen, P.J., Bindels, R.J., Smit, L.M., Busch, H.F., Wevers, R.A. J. Clin. Invest. (1994)
- Myoplasmic Ca2+ concentration during exertional rhabdomyolysis. López, J.R., Rojas, B., Gonzalez, M.A., Terzic, A. Lancet (1995)
- Azumolene Inhibits a Component of Store-operated Calcium Entry Coupled to the Skeletal Muscle Ryanodine Receptor. Zhao, X., Weisleder, N., Han, X., Pan, Z., Parness, J., Brotto, M., Ma, J. J. Biol. Chem. (2006)
- Phenelzine toxicity responsive to dantrolene. Verrilli, M.R., Salanga, V.D., Kozachuk, W.E., Bennetts, M. Neurology (1987)
- Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome. Nisijima, K., Noguti, M., Ishiguro, T. Biol. Psychiatry (1997)
- Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons. Frandsen, A., Schousboe, A. J. Neurochem. (1993)
- Dantrolene prevents glutamate cytotoxicity and Ca2+ release from intracellular stores in cultured cerebral cortical neurons. Frandsen, A., Schousboe, A. J. Neurochem. (1991)
- NMDA receptor activation-responsive phosphoproteins in the developing optic tectum. Scheetz, A.J., Constantine-Paton, M. J. Neurosci. (1996)
- Identification of dantrolene binding sites in porcine skeletal muscle sarcoplasmic reticulum. Parness, J., Palnitkar, S.S. J. Biol. Chem. (1995)
- Dantrolene stabilizes domain interactions within the ryanodine receptor. Kobayashi, S., Bannister, M.L., Gangopadhyay, J.P., Hamada, T., Parness, J., Ikemoto, N. J. Biol. Chem. (2005)
- Early postischemic dantrolene-induced amelioration of poly(ADP-ribose) polymerase-related bioenergetic failure in neonatal rat brain slices. Tasker, R.C., Sahota, S.K., Cotter, F.E., Williams, S.R. J. Cereb. Blood Flow Metab. (1998)
- Antispasticity drugs: mechanisms of action. Davidoff, R.A. Ann. Neurol. (1985)
- Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. Schneider, I., Reverse, D., Dewachter, I., Ris, L., Caluwaerts, N., Kuiperi, C., Gilis, M., Geerts, H., Kretzschmar, H., Godaux, E., Moechars, D., Van Leuven, F., Herms, J. J. Biol. Chem. (2001)
- Ryanodine receptor type I and nicotinic acid adenine dinucleotide phosphate receptors mediate Ca2+ release from insulin-containing vesicles in living pancreatic beta-cells (MIN6). Mitchell, K.J., Lai, F.A., Rutter, G.A. J. Biol. Chem. (2003)
- Ultraviolet light activates blocking actions of dantrolene on intracellular Ca2+ release in bullfrog sympathetic neurones. Nohmi, M., Kuba, K., Hua, S.Y. J. Biol. Chem. (1991)
- The temporal integration of the aldosterone secretory response to angiotensin occurs via two intracellular pathways. Kojima, I., Kojima, K., Kreutter, D., Rasmussen, H. J. Biol. Chem. (1984)
- NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release. Mody, I., MacDonald, J.F. Trends Pharmacol. Sci. (1995)
- Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. Fruen, B.R., Mickelson, J.R., Louis, C.F. J. Biol. Chem. (1997)
- An IP3-activated Ca2+ channel regulates fungal tip growth. Silverman-Gavrila, L.B., Lew, R.R. J. Cell. Sci. (2002)
- Biochemical characterization, distribution and phylogenetic analysis of Drosophila melanogaster ryanodine and IP3 receptors, and thapsigargin-sensitive Ca2+ ATPase. Vázquez-Martínez, O., Cañedo-Merino, R., Díaz-Muñoz, M., Riesgo-Escovar, J.R. J. Cell. Sci. (2003)
- Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity. Zhao, F., Li, P., Chen, S.R., Louis, C.F., Fruen, B.R. J. Biol. Chem. (2001)
- Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 alpha in a mouse model of endotoxin. Hotchkiss, R.S., Osborne, D.F., Lappas, G.D., Karl, I.E. Shock (1995)
- Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling. Conrad, D.M., Hanniman, E.A., Watson, C.L., Mader, J.S., Hoskin, D.W. J. Cell. Biochem. (2004)
- Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia. Hotchkiss, R.S., Karl, I.E. Proc. Natl. Acad. Sci. U.S.A. (1994)
- Hepatitis from dantrolene sodium. Wilkinson, S.P., Portmann, B., Williams, R. Gut (1979)
- Characterization of metabotropic glutamate receptor-mediated nitric oxide production in vivo. Bhardwaj, A., Northington, F.J., Martin, L.J., Hanley, D.F., Traystman, R.J., Koehler, R.C. J. Cereb. Blood Flow Metab. (1997)
- Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. Khan, A., Jaffe, J.H., Nelson, W.H., Morrison, B. The Journal of clinical psychiatry. (1985)